{"id":60132,"date":"2021-01-15T03:00:28","date_gmt":"2021-01-15T02:00:28","guid":{"rendered":"https:\/\/www.cde.ual.es\/?p=60132"},"modified":"2021-09-18T18:44:47","modified_gmt":"2021-09-18T16:44:47","slug":"commission-concludes-exploratory-talks-with-valneva-to-secure-a-new-potential-vaccine","status":"publish","type":"post","link":"https:\/\/www.cde.ual.es\/en\/commission-concludes-exploratory-talks-with-valneva-to-secure-a-new-potential-vaccine\/","title":{"rendered":"Commission concludes exploratory talks with Valneva to secure a new potential vaccine"},"content":{"rendered":"<p><strong>The European Commission concluded exploratory talks with the pharmaceutical company Valneva with a view to purchasing its potential vaccine against COVID-19.\u00a0<\/strong><\/p>\n<p><a href=\"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2020\/10\/vacuna.jpg\"><img decoding=\"async\" class=\"aligncenter wp-image-54403\" src=\"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2020\/10\/vacuna.jpg\" alt=\"Commission concludes exploratory talks with Valneva to secure a new potential vaccine\" width=\"490\" height=\"327\" srcset=\"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2020\/10\/vacuna.jpg 1920w, https:\/\/www.cde.ual.es\/wp-content\/uploads\/2020\/10\/vacuna-300x200.jpg 300w, https:\/\/www.cde.ual.es\/wp-content\/uploads\/2020\/10\/vacuna-1024x683.jpg 1024w, https:\/\/www.cde.ual.es\/wp-content\/uploads\/2020\/10\/vacuna-768x512.jpg 768w, https:\/\/www.cde.ual.es\/wp-content\/uploads\/2020\/10\/vacuna-1536x1024.jpg 1536w\" sizes=\"(max-width: 490px) 100vw, 490px\" \/><\/a><\/p>\n<p>The envisaged contract with Valneva would provide for the possibility for all EU Member States to purchase together 30 million doses, and they could further purchase up to 30 million more doses.<\/p>\n<p>This finalisation of exploratory talks with Valneva come in addition to an already secured broad portfolio of vaccines to be produced in Europe, including the contracts already signed with <a href=\"https:\/\/www.cde.ual.es\/en\/ema-receives-application-for-conditional-marketing-authorisation-of-covid-19-vaccine-astrazeneca\/\">AstraZeneca<\/a>,\u00a0<a href=\"https:\/\/ec.europa.eu\/commission\/presscorner\/detail\/en\/ip_20_1680\">Sanofi-GSK<\/a>,\u00a0<a href=\"https:\/\/ec.europa.eu\/commission\/presscorner\/detail\/en\/ip_20_1829\">Janssen Pharmaceutica NV<\/a>,\u00a0<a href=\"https:\/\/ec.europa.eu\/commission\/presscorner\/detail\/en\/ip_20_2081\">BioNtech-Pfize<\/a>r,\u00a0<a href=\"https:\/\/ec.europa.eu\/commission\/presscorner\/detail\/en\/ip_20_2136\">CureVac<\/a>, and\u00a0<a href=\"https:\/\/ec.europa.eu\/commission\/presscorner\/detail\/en\/ip_20_2200\">Moderna<\/a>\u00a0and exploratory talks concluded with\u00a0<a href=\"https:\/\/ec.europa.eu\/commission\/presscorner\/detail\/en\/ip_20_2305\">Novavax<\/a>. This diversified vaccines portfolio will ensure Europe is well prepared for vaccination, once the vaccines have been proven to be safe and effective, as is already the case for\u00a0<a href=\"https:\/\/ec.europa.eu\/commission\/presscorner\/detail\/en\/ip_20_2466\">BioNTech\/Pfizer<\/a>\u00a0and\u00a0<a href=\"https:\/\/ec.europa.eu\/commission\/presscorner\/detail\/en\/ip_21_3\">Moderna<\/a>, recently authorised in the EU. Member States are able to donate vaccines to lower and middle-income countries or to re-direct it to other European countries.<\/p>\n<p>President of the European Commission, Ursula\u00a0<strong>von der Leyen<\/strong>, said:<\/p>\n<blockquote><p><em>&#8220;The continuing COVID-19 pandemic in Europe and around the globe makes it more important than ever that all Member States have access to the broadest possible portfolio of vaccines to help protect people in Europe and beyond. Today&#8217;s step toward reaching an agreement with Valneva further complements the EU&#8217;s vaccines portfolio and demonstrates the Commission&#8217;s commitment to find a lasting solution to the pandemic.&#8221;<\/em><\/p><\/blockquote>\n<p>Valneva is a European biotechnology company developing an inactivated virus vaccine. This is a traditional vaccine technology, used for 60-70 years, with established methods and a high level of safety. Most of the influenza vaccines and many childhood vaccines use this technology. This is currently the only inactivated vaccine candidate in clinical trials against COVID-19 in Europe.<\/p>\n<p>The Commission, with the support of EU Member States, has taken a decision to support this vaccine based on a sound scientific assessment, the technology used, the company&#8217;s experience in vaccine development and its production capacity to supply all EU Member States.<\/p>\n<h3>More information<\/h3>\n<p><a href=\"https:\/\/ec.europa.eu\/commission\/presscorner\/detail\/es\/ip_21_51\" target=\"_blank\" rel=\"noopener\">Press release &#8211; European Commission<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The European Commission concluded exploratory talks with the pharmaceutical company Valneva with a view to purchasing its potential vaccine against COVID-19.\u00a0 The envisaged contract with Valneva would provide for the possibility for all EU Member States to purchase together 30 million doses, and they could further purchase up to 30 million more doses. This finalisation [&hellip;]<\/p>\n","protected":false},"author":101011,"featured_media":54403,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"","footnotes":""},"categories":[4093,346,4094,4092,4064],"tags":[1688,2565],"class_list":{"0":"post-60132","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-diseases","8":"category-eu-news","9":"category-farmac","10":"category-health","11":"category-institutional","12":"tag-vaccines","13":"tag-valneva-en","14":"entry"},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Commission concludes exploratory talks with Valneva to secure a new potential vaccine | CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cde.ual.es\/en\/commission-concludes-exploratory-talks-with-valneva-to-secure-a-new-potential-vaccine\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Commission concludes exploratory talks with Valneva to secure a new potential vaccine | CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda\" \/>\n<meta property=\"og:description\" content=\"The European Commission concluded exploratory talks with the pharmaceutical company Valneva with a view to purchasing its potential vaccine against COVID-19.\u00a0 The envisaged contract with Valneva would provide for the possibility for all EU Member States to purchase together 30 million doses, and they could further purchase up to 30 million more doses. This finalisation [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cde.ual.es\/en\/commission-concludes-exploratory-talks-with-valneva-to-secure-a-new-potential-vaccine\/\" \/>\n<meta property=\"og:site_name\" content=\"CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/cdeuniversidadalmeria\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-15T02:00:28+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-09-18T16:44:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2020\/10\/vacuna.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1280\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"BECA 2 CDE\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@cdeualmeria\" \/>\n<meta name=\"twitter:site\" content=\"@cdeualmeria\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"BECA 2 CDE\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/commission-concludes-exploratory-talks-with-valneva-to-secure-a-new-potential-vaccine\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/commission-concludes-exploratory-talks-with-valneva-to-secure-a-new-potential-vaccine\\\/\"},\"author\":{\"name\":\"BECA 2 CDE\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#\\\/schema\\\/person\\\/ee46ebc19edfa19598c02cff83335acc\"},\"headline\":\"Commission concludes exploratory talks with Valneva to secure a new potential vaccine\",\"datePublished\":\"2021-01-15T02:00:28+00:00\",\"dateModified\":\"2021-09-18T16:44:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/commission-concludes-exploratory-talks-with-valneva-to-secure-a-new-potential-vaccine\\\/\"},\"wordCount\":349,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/commission-concludes-exploratory-talks-with-valneva-to-secure-a-new-potential-vaccine\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cde.ual.es\\\/wp-content\\\/uploads\\\/2020\\\/10\\\/vacuna.jpg\",\"keywords\":[\"vaccines\",\"Valneva\"],\"articleSection\":[\"Diseases\",\"EU News\",\"Farmaceutical\",\"Health\",\"Institutional Affairs\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/commission-concludes-exploratory-talks-with-valneva-to-secure-a-new-potential-vaccine\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/commission-concludes-exploratory-talks-with-valneva-to-secure-a-new-potential-vaccine\\\/\",\"url\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/commission-concludes-exploratory-talks-with-valneva-to-secure-a-new-potential-vaccine\\\/\",\"name\":\"Commission concludes exploratory talks with Valneva to secure a new potential vaccine | CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/commission-concludes-exploratory-talks-with-valneva-to-secure-a-new-potential-vaccine\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/commission-concludes-exploratory-talks-with-valneva-to-secure-a-new-potential-vaccine\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cde.ual.es\\\/wp-content\\\/uploads\\\/2020\\\/10\\\/vacuna.jpg\",\"datePublished\":\"2021-01-15T02:00:28+00:00\",\"dateModified\":\"2021-09-18T16:44:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/commission-concludes-exploratory-talks-with-valneva-to-secure-a-new-potential-vaccine\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/commission-concludes-exploratory-talks-with-valneva-to-secure-a-new-potential-vaccine\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/commission-concludes-exploratory-talks-with-valneva-to-secure-a-new-potential-vaccine\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.cde.ual.es\\\/wp-content\\\/uploads\\\/2020\\\/10\\\/vacuna.jpg\",\"contentUrl\":\"https:\\\/\\\/www.cde.ual.es\\\/wp-content\\\/uploads\\\/2020\\\/10\\\/vacuna.jpg\",\"width\":1920,\"height\":1280},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/commission-concludes-exploratory-talks-with-valneva-to-secure-a-new-potential-vaccine\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inicio\",\"item\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EU News\",\"item\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/category\\\/eu-news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Health\",\"item\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/category\\\/eu-news\\\/health\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Diseases\",\"item\":\"https:\\\/\\\/www.cde.ual.es\\\/en\\\/category\\\/eu-news\\\/health\\\/diseases\\\/\"},{\"@type\":\"ListItem\",\"position\":5,\"name\":\"Commission concludes exploratory talks with Valneva to secure a new potential vaccine\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#website\",\"url\":\"https:\\\/\\\/www.cde.ual.es\\\/\",\"name\":\"CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda\",\"description\":\"Centro de Documentaci\u00f3n Europea de la Universidad de Almer\u00eda\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#organization\"},\"alternateName\":\"CDE Almer\u00eda\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cde.ual.es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#organization\",\"name\":\"Centro de Documentaci\u00f3n Europea de Almer\u00eda\",\"url\":\"https:\\\/\\\/www.cde.ual.es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.cde.ual.es\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/cde-logo-3.png\",\"contentUrl\":\"https:\\\/\\\/www.cde.ual.es\\\/wp-content\\\/uploads\\\/2025\\\/07\\\/cde-logo-3.png\",\"width\":1400,\"height\":300,\"caption\":\"Centro de Documentaci\u00f3n Europea de Almer\u00eda\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/cdeuniversidadalmeria\\\/\",\"https:\\\/\\\/x.com\\\/cdeualmeria\",\"https:\\\/\\\/www.tiktok.com\\\/@cdealmeria\",\"https:\\\/\\\/www.instagram.com\\\/cdealmeria\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/in\\\/cde-almera-812b26a9\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.cde.ual.es\\\/#\\\/schema\\\/person\\\/ee46ebc19edfa19598c02cff83335acc\",\"name\":\"BECA 2 CDE\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/35a481bbc04bbd90e91bdfa3b0b5541036c222a49b9ad37b6889a2afcb5311a5?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/35a481bbc04bbd90e91bdfa3b0b5541036c222a49b9ad37b6889a2afcb5311a5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/35a481bbc04bbd90e91bdfa3b0b5541036c222a49b9ad37b6889a2afcb5311a5?s=96&d=mm&r=g\",\"caption\":\"BECA 2 CDE\"},\"sameAs\":[\"http:\\\/\\\/www.cdealmeria.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Commission concludes exploratory talks with Valneva to secure a new potential vaccine | CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cde.ual.es\/en\/commission-concludes-exploratory-talks-with-valneva-to-secure-a-new-potential-vaccine\/","og_locale":"en_US","og_type":"article","og_title":"Commission concludes exploratory talks with Valneva to secure a new potential vaccine | CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda","og_description":"The European Commission concluded exploratory talks with the pharmaceutical company Valneva with a view to purchasing its potential vaccine against COVID-19.\u00a0 The envisaged contract with Valneva would provide for the possibility for all EU Member States to purchase together 30 million doses, and they could further purchase up to 30 million more doses. This finalisation [&hellip;]","og_url":"https:\/\/www.cde.ual.es\/en\/commission-concludes-exploratory-talks-with-valneva-to-secure-a-new-potential-vaccine\/","og_site_name":"CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda","article_publisher":"https:\/\/www.facebook.com\/cdeuniversidadalmeria\/","article_published_time":"2021-01-15T02:00:28+00:00","article_modified_time":"2021-09-18T16:44:47+00:00","og_image":[{"width":1920,"height":1280,"url":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2020\/10\/vacuna.jpg","type":"image\/jpeg"}],"author":"BECA 2 CDE","twitter_card":"summary_large_image","twitter_creator":"@cdeualmeria","twitter_site":"@cdeualmeria","twitter_misc":{"Written by":"BECA 2 CDE","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cde.ual.es\/en\/commission-concludes-exploratory-talks-with-valneva-to-secure-a-new-potential-vaccine\/#article","isPartOf":{"@id":"https:\/\/www.cde.ual.es\/en\/commission-concludes-exploratory-talks-with-valneva-to-secure-a-new-potential-vaccine\/"},"author":{"name":"BECA 2 CDE","@id":"https:\/\/www.cde.ual.es\/#\/schema\/person\/ee46ebc19edfa19598c02cff83335acc"},"headline":"Commission concludes exploratory talks with Valneva to secure a new potential vaccine","datePublished":"2021-01-15T02:00:28+00:00","dateModified":"2021-09-18T16:44:47+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cde.ual.es\/en\/commission-concludes-exploratory-talks-with-valneva-to-secure-a-new-potential-vaccine\/"},"wordCount":349,"commentCount":0,"publisher":{"@id":"https:\/\/www.cde.ual.es\/#organization"},"image":{"@id":"https:\/\/www.cde.ual.es\/en\/commission-concludes-exploratory-talks-with-valneva-to-secure-a-new-potential-vaccine\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2020\/10\/vacuna.jpg","keywords":["vaccines","Valneva"],"articleSection":["Diseases","EU News","Farmaceutical","Health","Institutional Affairs"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.cde.ual.es\/en\/commission-concludes-exploratory-talks-with-valneva-to-secure-a-new-potential-vaccine\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.cde.ual.es\/en\/commission-concludes-exploratory-talks-with-valneva-to-secure-a-new-potential-vaccine\/","url":"https:\/\/www.cde.ual.es\/en\/commission-concludes-exploratory-talks-with-valneva-to-secure-a-new-potential-vaccine\/","name":"Commission concludes exploratory talks with Valneva to secure a new potential vaccine | CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda","isPartOf":{"@id":"https:\/\/www.cde.ual.es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cde.ual.es\/en\/commission-concludes-exploratory-talks-with-valneva-to-secure-a-new-potential-vaccine\/#primaryimage"},"image":{"@id":"https:\/\/www.cde.ual.es\/en\/commission-concludes-exploratory-talks-with-valneva-to-secure-a-new-potential-vaccine\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2020\/10\/vacuna.jpg","datePublished":"2021-01-15T02:00:28+00:00","dateModified":"2021-09-18T16:44:47+00:00","breadcrumb":{"@id":"https:\/\/www.cde.ual.es\/en\/commission-concludes-exploratory-talks-with-valneva-to-secure-a-new-potential-vaccine\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cde.ual.es\/en\/commission-concludes-exploratory-talks-with-valneva-to-secure-a-new-potential-vaccine\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.cde.ual.es\/en\/commission-concludes-exploratory-talks-with-valneva-to-secure-a-new-potential-vaccine\/#primaryimage","url":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2020\/10\/vacuna.jpg","contentUrl":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2020\/10\/vacuna.jpg","width":1920,"height":1280},{"@type":"BreadcrumbList","@id":"https:\/\/www.cde.ual.es\/en\/commission-concludes-exploratory-talks-with-valneva-to-secure-a-new-potential-vaccine\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inicio","item":"https:\/\/www.cde.ual.es\/en\/"},{"@type":"ListItem","position":2,"name":"EU News","item":"https:\/\/www.cde.ual.es\/en\/category\/eu-news\/"},{"@type":"ListItem","position":3,"name":"Health","item":"https:\/\/www.cde.ual.es\/en\/category\/eu-news\/health\/"},{"@type":"ListItem","position":4,"name":"Diseases","item":"https:\/\/www.cde.ual.es\/en\/category\/eu-news\/health\/diseases\/"},{"@type":"ListItem","position":5,"name":"Commission concludes exploratory talks with Valneva to secure a new potential vaccine"}]},{"@type":"WebSite","@id":"https:\/\/www.cde.ual.es\/#website","url":"https:\/\/www.cde.ual.es\/","name":"CDE Almer\u00eda - Centro de Documentaci\u00f3n Europea - Universidad de Almer\u00eda","description":"Centro de Documentaci\u00f3n Europea de la Universidad de Almer\u00eda","publisher":{"@id":"https:\/\/www.cde.ual.es\/#organization"},"alternateName":"CDE Almer\u00eda","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cde.ual.es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.cde.ual.es\/#organization","name":"Centro de Documentaci\u00f3n Europea de Almer\u00eda","url":"https:\/\/www.cde.ual.es\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.cde.ual.es\/#\/schema\/logo\/image\/","url":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2025\/07\/cde-logo-3.png","contentUrl":"https:\/\/www.cde.ual.es\/wp-content\/uploads\/2025\/07\/cde-logo-3.png","width":1400,"height":300,"caption":"Centro de Documentaci\u00f3n Europea de Almer\u00eda"},"image":{"@id":"https:\/\/www.cde.ual.es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/cdeuniversidadalmeria\/","https:\/\/x.com\/cdeualmeria","https:\/\/www.tiktok.com\/@cdealmeria","https:\/\/www.instagram.com\/cdealmeria\/","https:\/\/www.linkedin.com\/in\/cde-almera-812b26a9\/"]},{"@type":"Person","@id":"https:\/\/www.cde.ual.es\/#\/schema\/person\/ee46ebc19edfa19598c02cff83335acc","name":"BECA 2 CDE","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/35a481bbc04bbd90e91bdfa3b0b5541036c222a49b9ad37b6889a2afcb5311a5?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/35a481bbc04bbd90e91bdfa3b0b5541036c222a49b9ad37b6889a2afcb5311a5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/35a481bbc04bbd90e91bdfa3b0b5541036c222a49b9ad37b6889a2afcb5311a5?s=96&d=mm&r=g","caption":"BECA 2 CDE"},"sameAs":["http:\/\/www.cdealmeria.com"]}]}},"_links":{"self":[{"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/posts\/60132","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/users\/101011"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/comments?post=60132"}],"version-history":[{"count":0,"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/posts\/60132\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/media\/54403"}],"wp:attachment":[{"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/media?parent=60132"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/categories?post=60132"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cde.ual.es\/en\/wp-json\/wp\/v2\/tags?post=60132"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}